AMRI

Albany Molecular Research Inc
AMRI

Overview Fund Activity
Delisted

AMRI was delisted on the 31st of August, 2017.

Back to rankings

143 hedge funds and large institutions have $669M invested in Albany Molecular Research Inc in 2014 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 46 increasing their positions, 42 reducing their positions, and 14 closing their positions.

Holders
143
Holders Change
+11
Holders Change %
+8.33%
% of All Funds
4.15%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.12%
New
25
Increased
46
Reduced
42
Closed
14
Calls
$1.95M
Puts
$1.05M
Net Calls
+$899K
Net Calls Change
-$5.29M

Top Buyers

1
Morgan Stanley
1
Morgan Stanley
New York
$36.9M
2
BM
2
Bridger Management
New York
$18M
3
WIC
3
Wood Investment Counsel
Colorado
$16.2M
4
PIP
4
Permian Investment Partners
Texas
$30M
5
HM
5
HealthCor Management
New York
$30.9M

Top Sellers

1
VAM
1
Visium Asset Management
New York
$26.5M
2
Renaissance Technologies
2
Renaissance Technologies
New York
$4.62M
3
Wellington Management Group
3
Wellington Management Group
Massachusetts
$27.2M
4
DCM
4
Decade Capital Management
New York
$8.83M
5
DS
5
DRW Securities
Illinois
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
TAM
151
Thornmark Asset Management
Ontario, Canada
– -$294K -14,600 Closed
TDC
152
Thompson Davis & Co
Virginia
– -$235K -11,700 Closed
CEP
153
Chicago Equity Partners
Illinois
– -$218K -10,870 Closed
U
154
UBS
Switzerland
– -$93K -4,645 Closed
VFA
155
Virtus Fund Advisers
Connecticut
– -$40K -2,009 Closed
3 4 5 6
7